| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Numismatics are for Collectors, Not Investors |
|
Advice Pool - Numismatics are for Collectors, Not Investors
As a precious metals investor, you may heard much about numismatic and "semi-numismatic" coins, particularly the St. Gaudens $20 double eagle gold coin. While According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product coin collecting can be an interesting hobby, it is not necessarily related to metals investing. Coins of this type vary in value with the ebb and flow of the c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ollector market and are not strictly tied to metal value. Also, these coins often go for much more over spot price than bullion coins. One of the concepts tha lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. gets bandied about quite a bit is the idea of U.S. government confiscation. While it is true that the U.S. government did have a gold recall in 1933 by execut here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ive order of FDR, gold coins of a significant value over gold value were not subject to this recall. Many dealers use this to imply that in the event of anothe d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro r confiscation these older coins would fall in this category in order to sell these types of coins to the unsuspecting or newer metals investor. However, the c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nfiscation issue is a red herring for several reasons:
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e run on banks; the dollar no longer has any metal backing.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically on even considering their age due to decades of mass storage in European bank vaults.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ confiscated in the event of another recall; the original executive order no longer has any force of law.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi coinage (the American Eagle gold coin, although it has a face value, does not count) and is typically used only in jewelry and privately-held investment vehic ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a les such as bars and bullion coins which would be harder to recall and account for. The majority of recalled gold coinage in 1933 was housed in bank vaults. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod >
Now, you may be wondering cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin about silver in regards to this as well. Silver held sway as coinage for longer than gold, and some silver coins can still be found in circulation. However, s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ilver has never been subject to confiscation, and its status as an important industrial metal gives good reason to believe that there will never be a silver re t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel all. 90% and 40% silver U.S. coinage is still widely available, and although it sounds contrary to what I stated above, these coins are a good value - as l ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ong as they can be bought at near silver spot or less. This is an important distinction to make, as old silver coinage (often referred to as junk silver) o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ften carries very little to no value as a collector item over the metal value. These coins, if anything, are semi-numismatic, but don't bank on collector value . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de In short, if you approach this from the perspective of a metals investor never look at a coin for collector value. Collector markets are often hard to get a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip pulse on, and numismatics are much more illiquid than their bullion counterparts. If you're paying more than spot plus a modest premium, you're paying too much tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Building A Successful Business In Ten Steps - Step 1 - Suss Your Competition
|